Fig. 3.

Involvement of T cells in tumor growth inhibition. a Mice bearing subcutaneous tumors were infused with 5 × 10⁶ allogeneic whole bone marrow cells (wBMC, n = 19) or T cell depleted (TCD) BMC (n = 26) according to the experimental sequence detailed in Fig. 1b. Data represent means ± SD. b Recipients allografted with 5 × 10⁶ TCD-BMC (H2 K^b) were infused intravenously with 2 × 10⁷ splenocytes (F1 spln.) from F1 mice (H2K^a/b) on days 0 or 7 and on both days (0 + 7)